Perspective Therapeutics, Inc. (CATX) Ownership
CATX ownership summary
as of October 17, 2026- Institutions
- 86.0% of shares outstanding
- Insiders
- 8.23% of shares outstanding
- Shares outstanding
- 114.2M
- Float
- 70.8M shares available to trade
- Short interest
- 17.34% 16.6M shares short
- Days to cover
- 7.68 short interest down 29.0% vs prior month
- Institutions 86.02%
- Insiders 8.23%
- Other investors 5.75%
CATX insider transactions
latest 2| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-11-13 | Jonathan Robert Hunt | Buy | $2.03 | 11,000 | $22,330 |
| 2025-11-12 | Robert F Williamson III | Buy | $2.10 | 9,498 | $19,946 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
CATX shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns CATX
Institutional investors own 86.0% of Perspective Therapeutics's shares and insiders 8.23%. Short interest is 17.34% of the float, or 7.68 days of average trading volume. The share count rose 35.4% since 2014.
Related: CATX analyst forecast, CATX key metrics. See the CATX stock overview for the latest quote and news.
CATX ownership FAQ
What percentage of Perspective Therapeutics is owned by institutions?
Institutions hold 86.0% of Perspective Therapeutics's shares outstanding; insiders hold 8.23%.
What is Perspective Therapeutics's short interest?
16.6M shares of Perspective Therapeutics were sold short, 17.34% of the float; at the average daily volume it would take 7.68 days to cover.
Are insiders buying or selling Perspective Therapeutics?
Of the latest 2 reported insider transactions in Perspective Therapeutics (since November 12, 2025), 2 were purchases and 0 were sales.
How many shares of Perspective Therapeutics are outstanding?
Perspective Therapeutics has 114.2M shares outstanding, of which 70.8M are in the public float.